PUBLISHER: BCC Research | PRODUCT CODE: 1303160
PUBLISHER: BCC Research | PRODUCT CODE: 1303160
The U.S. market for fertility clinic services is estimated to increase from $8.9 billion in 2023 to reach $16.8 billion by 2028, at a compound annual growth rate (CAGR) of 13.6% from 2023 through 2028.
The assisted reproductive technology (ART) segment of the U.S. fertility clinic services market is estimated to increase from $7.1 billion in 2023 to reach $13.7 billion by 2028, at a CAGR of 14.2% from 2023 through 2028.
The diagnostic services segment of the U.S. fertility clinic services market is estimated to increase from $1.3 billion in 2023 to reach $2.3 billion by 2028, at a CAGR of 12.0% from 2023 through 2028.
The scope of this report is broad and covers emerging trends in the U.S. fertility clinic market. No other geographic regions are covered. This report segments the U.S. fertility clinic market into assisted reproductive technology, diagnostic services and surgeries.
This report highlights the current and future market potential and provides a detailed analysis of the market's drivers, challenges and opportunities. For market estimates, data has been provided for 2020, 2021 and 2022 (as the base year), along with a forecast for 2028. The report also analyzes the market shares of leading companies and includes profiles of the major players in the market. It also analyzes the impact of the COVID-19 pandemic on the U.S. fertility clinic market.
Table A : New Chapters in the Report